Omicron may sideline two leading drugs against COVID-19
WASHINGTON (AP) — As strained U.S. hospitals brace for a new surge of COVID-19 cases...
Stay updated with breaking news from James Cutrell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WASHINGTON (AP) — As strained U.S. hospitals brace for a new surge of COVID-19 cases...
WASHINGTON (AP) — As strained U.S. hospitals brace for a new surge of COVID-19 cases...
WASHINGTON (AP) — As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain.
Virologist predicts shortage of GlaxoSmithKline's drug, the only one that remains effective, after Regeneron, Eli Lilly say their therapies appear less useful against new strain
The omicron variant of the coronavirus makes up nearly 3% of COVID-19 cases in the US. The CDC has detected the new strain in 43 states. Latest news.